Report cover image

Cannabidiol Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Published Mar 27, 2026
Length 187 Pages
SKU # PERR21042827

Description

Persistence Market Research has recently released a comprehensive report on the global Cannabidiol Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:
  • Cannabidiol Market Size (2025E): US$ 8.9 Bn
  • Projected Market Value (2032F): US$ 28.7 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 18.2%
Cannabidiol Market - Report Scope:

The cannabidiol (CBD) market encompasses products derived from hemp and marijuana plants that are used across a wide range of applications, including medical treatments, wellness products, pharmaceuticals, and personal use items. CBD is widely recognized for its therapeutic properties such as pain relief, anxiety reduction, and anti-inflammatory effects. The growing legalization of cannabis in various regions, increasing consumer awareness regarding health benefits, and rising demand for natural and plant-based products are significantly contributing to the expansion of the cannabidiol market globally.

Market Growth Drivers:

The global cannabidiol market is experiencing strong growth due to increasing awareness about the therapeutic benefits of CBD, particularly in managing chronic pain, anxiety, epilepsy, and sleep disorders. The growing legalization of cannabis for medical and recreational purposes across several countries has significantly boosted product availability and consumer acceptance. Additionally, the rising demand for natural and plant-based wellness products is encouraging consumers to shift toward CBD-infused products. The expansion of e-commerce platforms and B2C channels has further facilitated easy access to CBD products, thereby accelerating market growth.

Market Restraints:

Despite its rapid expansion, the cannabidiol market faces several challenges, including stringent regulatory frameworks and varying legal statuses across different regions, which create uncertainty for manufacturers and distributors. Quality control issues and lack of standardization in CBD products can impact consumer trust and hinder market growth. Furthermore, potential side effects and limited clinical research on long-term usage may restrict widespread adoption, especially in conservative markets.

Market Opportunities:

The cannabidiol market presents substantial opportunities driven by ongoing research and development activities focused on expanding medical applications of CBD. Increasing investments by pharmaceutical companies in CBD-based drug development are expected to open new avenues for market growth. Emerging markets in Asia-Pacific and Latin America offer untapped potential due to evolving regulatory landscapes and rising consumer awareness. Additionally, product innovation, including CBD-infused food, beverages, and cosmetics, is expected to create new growth prospects for market players.

Key Questions Answered in the Report:
  • What are the primary factors driving the global cannabidiol market's growth?
  • Which regions and market segments are experiencing the highest demand for cannabidiol products?
  • How are regulatory frameworks influencing market dynamics?
  • Who are the key players in the cannabidiol market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global cannabidiol market?
Competitive Intelligence and Business Strategy:

Leading companies in the global cannabidiol market are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their market position. These players are investing in research and development to enhance product quality, efficacy, and safety standards. Collaborations with healthcare providers and pharmaceutical companies are enabling the development of advanced CBD-based therapeutics. In addition, companies are expanding their distribution networks through online and offline channels to reach a broader consumer base and gain a competitive advantage.

Companies Covered in This Report:
  • ENDOCA
  • Cannoid LLC
  • Medical Marijuana Inc.
  • Folium Europe B.V.
  • Canopy Growth Corporation
  • Elixinol
  • NuLeaf Naturals LLC
  • Isodiol International Inc.
  • PharmaHemp
  • The Cronos Group
Market Segmentation

By Source Type
  • Hemp
  • Marijuana
By Sales Type
  • B2B
  • B2C
By End-use
  • Medical
  • Personal Use
  • Pharmaceuticals
  • Wellness
By Region
  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa


Please Note: It will take 5 business days to complete the report upon order confirmation.

Table of Contents

187 Pages
1. Executive Summary
1.1. Global Cannabidiol Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Value Chain Analysis
3.2. Key Market Players
3.3. Regulatory Landscape
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
3.6. Consumer Behavior Analysis
4. Price Trend Analysis, 2019 - 2032
4.1. Key Factors Impacting Product Prices
4.2. Pricing Analysis, By Source Type
4.3. Regional Prices and Product Preferences
5. Global Cannabidiol Market Outlook
5.1. Market Size (US$ Bn) Analysis and Forecast
5.1.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
5.1.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
5.2. Global Cannabidiol Market Outlook: Source Type
5.2.1. Historical Market Size (US$ Bn) Analysis, By Source Type, 2019-2024
5.2.2. Market Size (US$ Bn) Analysis and Forecast, By Source Type, 2025-2032
5.2.2.1. Hemp
5.2.2.2. Marijuana
5.2.3. Market Attractiveness Analysis: Source Type
5.3. Global Cannabidiol Market Outlook: Sales Type
5.3.1. Historical Market Size (US$ Bn) Analysis, By Sales Type, 2019-2024
5.3.2. Market Size (US$ Bn) Analysis and Forecast, By Sales Type, 2025-2032
5.3.2.1. B2B
5.3.2.2. B2C
5.3.3. Market Attractiveness Analysis: Sales Type
5.4. Global Cannabidiol Market Outlook: End-use
5.4.1. Historical Market Size (US$ Bn) Analysis, By End-use, 2019-2024
5.4.2. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
5.4.2.1. Medical
5.4.2.2. Personal Use
5.4.2.3. Pharmaceuticals
5.4.2.4. Wellness
5.4.3. Market Attractiveness Analysis: End-use
6. Global Cannabidiol Market Outlook: Region
6.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
6.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. East Asia
6.2.5. South Asia and Oceania
6.2.6. Middle East & Africa
6.3. Market Attractiveness Analysis: Region
7. North America Cannabidiol Market Outlook
7.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.1.1. By Country
7.1.2. By Source Type
7.1.3. By Sales Type
7.1.4. By End-use
7.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Bn) Analysis and Forecast, By Source Type, 2025-2032
7.3.1. Hemp
7.3.2. Marijuana
7.4. Market Size (US$ Bn) Analysis and Forecast, By Sales Type, 2025-2032
7.4.1. B2B
7.4.2. B2C
7.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
7.5.1. Medical
7.5.2. Personal Use
7.5.3. Pharmaceuticals
7.5.4. Wellness
7.6. Market Attractiveness Analysis
8. Europe Cannabidiol Market Outlook
8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.1.1. By Country
8.1.2. By Source Type
8.1.3. By Sales Type
8.1.4. By End-use
8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.2.1. Germany
8.2.2. France
8.2.3. U.K.
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Market Size (US$ Bn) Analysis and Forecast, By Source Type, 2025-2032
8.3.1. Hemp
8.3.2. Marijuana
8.4. Market Size (US$ Bn) Analysis and Forecast, By Sales Type, 2025-2032
8.4.1. B2B
8.4.2. B2C
8.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
8.5.1. Medical
8.5.2. Personal Use
8.5.3. Pharmaceuticals
8.5.4. Wellness
8.6. Market Attractiveness Analysis
9. East Asia Cannabidiol Market Outlook
9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.1.1. By Country
9.1.2. By Source Type
9.1.3. By Sales Type
9.1.4. By End-use
9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.3. Market Size (US$ Bn) Analysis and Forecast, By Source Type, 2025-2032
9.3.1. Hemp
9.3.2. Marijuana
9.4. Market Size (US$ Bn) Analysis and Forecast, By Sales Type, 2025-2032
9.4.1. B2B
9.4.2. B2C
9.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
9.5.1. Medical
9.5.2. Personal Use
9.5.3. Pharmaceuticals
9.5.4. Wellness
9.6. Market Attractiveness Analysis
10. South Asia & Oceania Cannabidiol Market Outlook
10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.1.1. By Country
10.1.2. By Source Type
10.1.3. By Sales Type
10.1.4. By End-use
10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.2.1. India
10.2.2. Indonesia
10.2.3. Thailand
10.2.4. Singapore
10.2.5. ANZ
10.2.6. Rest of South Asia & Oceania
10.3. Market Size (US$ Bn) Analysis and Forecast, By Source Type, 2025-2032
10.3.1. Hemp
10.3.2. Marijuana
10.4. Market Size (US$ Bn) Analysis and Forecast, By Sales Type, 2025-2032
10.4.1. B2B
10.4.2. B2C
10.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
10.5.1. Medical
10.5.2. Personal Use
10.5.3. Pharmaceuticals
10.5.4. Wellness
10.6. Market Attractiveness Analysis
11. Latin America Cannabidiol Market Outlook
11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.1.1. By Country
11.1.2. By Source Type
11.1.3. By Sales Type
11.1.4. By End-use
11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.2.1. Brazil
11.2.2. Mexico
11.2.3. Rest of Latin America
11.3. Market Size (US$ Bn) Analysis and Forecast, By Source Type, 2025-2032
11.3.1. Hemp
11.3.2. Marijuana
11.4. Market Size (US$ Bn) Analysis and Forecast, By Sales Type, 2025-2032
11.4.1. B2B
11.4.2. B2C
11.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
11.5.1. Medical
11.5.2. Personal Use
11.5.3. Pharmaceuticals
11.5.4. Wellness
11.6. Market Attractiveness Analysis
12. Middle East & Africa Cannabidiol Market Outlook
12.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.1.1. By Country
12.1.2. By Source Type
12.1.3. By Sales Type
12.1.4. By End-use
12.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.2.1. GCC Countries
12.2.2. Egypt
12.2.3. South Africa
12.2.4. Northern Africa
12.2.5. Rest of Middle East & Africa
12.3. Market Size (US$ Bn) Analysis and Forecast, By Source Type, 2025-2032
12.3.1. Hemp
12.3.2. Marijuana
12.4. Market Size (US$ Bn) Analysis and Forecast, By Sales Type, 2025-2032
12.4.1. B2B
12.4.2. B2C
12.5. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
12.5.1. Medical
12.5.2. Personal Use
12.5.3. Pharmaceuticals
12.5.4. Wellness
12.6. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. ENDOCA
13.3.1.1. Overview
13.3.1.2. Segments and Source Type
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Cannoid LLC
13.3.3. Medical Marijuana Inc.
13.3.4. Folium Europe B.V.
13.3.5. Canopy Growth Corporation
13.3.6. Elixinol
13.3.7. NuLeaf Naturals LLC
13.3.8. Isodiol International Inc.
13.3.9. PharmaHemp
13.3.10. The Cronos Group.
13.3.11. Others
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.